Heparina Galenika (Heparin)

It is commonly prescribed for prevention and treatment of deep vein thrombosis, pulmonary embolism, anticoagulation during cardiac surgery or dialysis, and to prevent clot formation in arterial and venous grafts.

Heparina Galenika is supplied as an injectable solution and is administered intravenously under medical supervision.

Heparina Galenika is classified as Pregnancy Category B, indicating no evidence of risk in animal studies, but it should only be used in pregnancy when clearly needed and under specialist guidance.

Patients typically require regular monitoring of coagulation parameters (e.g., activated partial thromboplastin time) and platelet counts to detect bleeding or heparin‑induced thrombocytopenia.

Combining Heparina Galenika with aspirin or other antiplatelet agents increases bleeding risk and should be avoided unless closely monitored by a healthcare professional.

Serious bleeding may present as unexplained bruising, blood in urine or stool, coughing up blood, severe headache, or neurological changes suggesting intracranial hemorrhage.

HIT is an immune‑mediated reaction where heparin triggers platelet activation, leading to a drop in platelet count and paradoxical clot formation. It is a recognized serious adverse effect of heparin products, including Heparina Galenika.

There are no specific dietary restrictions, but patients should avoid foods or supplements that may increase bleeding risk, such as high‑dose vitamin K or herbal products with anticoagulant properties.

Heparina Galenika is administered intravenously in a controlled setting; missed doses should be addressed by the treating clinician, who will determine the appropriate timing and monitoring.

Most heparin products, including Heparina Galenika, are derived from porcine intestinal mucosa, so patients with pork allergies should discuss alternatives with their physician.

Renal impairment can alter heparin clearance, potentially increasing anticoagulant effect; dose adjustments and more frequent monitoring may be required in patients with reduced kidney function.